ArticleThe international journal of cardiovascular imaging2026
Mitral annular disjunction and mitral valve prolapse: echocardiographic-MRI insights into cardiac function.
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Arrhythmic Mitral Valve Prolapse as a Regional Stretch-Induced Cardiomyopathy with Fibro-Inflammatory Signature: A Conceptual Review.Journal of cardiovascular development and disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMitral annular disjunction (MAD) may accompany mitral valve prolapse (MVP) and is linked to ventricular arrhythmias. Its impact on global cardiac performance (specifically cardiac index (CI) and output (CO)), remains incompletely defined. Cardiac MRI (CMR) allows precise measurement of MAD, assessment of mitral annular dynamics, and detection of myocardial fibrosis via late gadolinium enhancement (LGE). We investigated both CMR and TTE metrics in patients with varying degrees of MAD compared to MVP-only. METHODS AND
resultsFifty-six patients who underwent CMR and TTE (mean age 61, 33 female) were divided into MAD ≥2 mm and MVP (the "MAD + MVP" group, n = 41) or MVP-only (n = 15). MAD was classified as <5 mm, ≥5 mm, and ≥ 10 mm in peak systole after excluding pseudo-MAD. LV volume, stroke volume, ejection fraction, cardiac output (CO), cardiac index (CI), mitral regurgitation (MR), and LGE were assessed. Any MAD was associated with lower CI versus MVP-only (p = 0.03). MAD ≥5 mm and MAD ≥ 10 mm showed reduced CO (p = 0.04 and 0.04, respectively) and CI (p = 0.04 and 0.03, respectively) versus MVP-only. LGE was more frequent in MAD ≥ 10 mm than in MAD < 10 mm (p = 0.028). MR incidence, volume, or fraction did not differ across groups. TTE showed agreement with CMR in MAD detection and quantification (p = 0.269), with minimal inter-observer variability (p < 0.001).
conclusionMAD is associated with impaired cardiac performance independent of MR and with increased myocardial fibrosis in severe cases. These findings suggest heightened electromechanical stress in MAD compared to MVP-only, which needs to be clinically correlated. TTE reliably detects and quantifies MAD, supporting its use alongside CMR for assessment of MAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.